SCHEMBL3898401

SCHEMBL3898401

Nc1ccc(NC=O)c2c1C(=O)c1cscc1-2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.41
CSNK1A1 P48729 2/20 0.41
CSNK1D P48730 2/20 0.41
CSNK1G1 Q9HCP0 2/20 0.41
FGR P09769 1/20 0.41
PIM1 P11309 1/20 0.41
MAOA P21397 1/20 0.41
DYRK1A Q13627 1/20 0.41
HIPK2 Q9H2X6 1/20 0.41
THRB P10828 3/20 0.38
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
MMP14 P50281 1/20 0.37
POLB P06746 4/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPT P10636 3/20 0.35
PABPC1 P11940 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
BLM P54132 2/20 0.35
MCL1 Q07820 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27704370 0.80 ADORA2A (0.63) ADORA2ACSNK1A1CSNK1DCSNK1G1FGR
SCHEMBL3902083 0.79 PABPC1 (0.33) MAOATHRBMEN1KMT2APOLB
SCHEMBL3900430 0.76 THRB (0.35) ADORA2ACSNK1A1CSNK1DCSNK1G1FGR
SCHEMBL3898322 0.74 ADORA2A (0.48) ADORA2ACSNK1A1CSNK1DCSNK1G1FGR
SCHEMBL3902071 0.72 ADORA2A (0.61) ADORA2ACSNK1A1CSNK1DCSNK1G1FGR
SCHEMBL14612359 0.71 ADORA2A (0.54) ADORA2ACSNK1A1CSNK1DCSNK1G1FGR
SCHEMBL3897409 0.70
SCHEMBL3909101 0.69 MAPT (0.64) ADORA2ACSNK1A1CSNK1DCSNK1G1FGR
SCHEMBL15453235 0.68 PABPC1 (0.50) ADORA2ACSNK1A1CSNK1DCSNK1G1FGR
SCHEMBL8247267 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383463-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS INC (US) 2009-03-25 EP disclosed
EP-1383463-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE King Pharmaceuticals, Inc. (US) 2004-01-28 EP disclosed
WO-2002083083-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS, INC. (US) 2002-10-24 WO disclosed